Baird Downgrades Doximity to Neutral, Lowers Price Target to $18
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
Baird analyst Vikram Kesavabhotla downgrades Doximity (NYSE:
DOCS) from Outperform to Neutral and lowers the price target from $40 to $18.
